Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiomyocyte—Endothelial Cell Interactions in Cardiac Remodeling and Regeneration
Virpi Talman, Riikka Kivelä
Frontiers in Cardiovascular Medicine (2018) Vol. 5
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes
Razan E. Ahmed, Tatsuya Anzai, Nawin Chanthra, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 198
Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control
Xing Chang, Amanda Lochner, Hsueh-Hsiao Wang, et al.
Theranostics (2021) Vol. 11, Iss. 14, pp. 6766-6785
Open Access | Times Cited: 185
Cardiomyocyte Senescence and Cellular Communications Within Myocardial Microenvironments
Xiaoqiang Tang, Peiheng Li, Hou‐Zao Chen
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 157
Vascular Endothelial Cells: Heterogeneity and Targeting Approaches
Jan K. Hennigs, Christiane Matuszcak, Martin Trepel, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2712-2712
Open Access | Times Cited: 120
Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications
Sungjin Min, Suran Kim, Woo‐Sup Sim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 28
Cardiac Remodeling in Chronic Kidney Disease
Nadine Kaesler, Anne Babler, Jürgen Floege, et al.
Toxins (2020) Vol. 12, Iss. 3, pp. 161-161
Open Access | Times Cited: 115
circRNA Hipk3 Induces Cardiac Regeneration after Myocardial Infarction in Mice by Binding to Notch1 and miR-133a
Xiaoyun Si, Hao Zheng, Guoquan Wei, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 21, pp. 636-655
Open Access | Times Cited: 114
Matters of the heart: Cellular sex differences
Cierra J. Walker, Megan E. Schroeder, Brian A. Aguado, et al.
Journal of Molecular and Cellular Cardiology (2021) Vol. 160, pp. 42-55
Open Access | Times Cited: 64
Opportunities and challenges in cardiac tissue engineering from an analysis of two decades of advances
Richard Z. Zhuang, Roberta I. Lock, Bohao Liu, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 4, pp. 327-338
Closed Access | Times Cited: 56
3D Biofabrication of a Cardiac Tissue Construct for Sustained Longevity and Function
Matthew Alonzo, Raven El Khoury, Naveen Nagiah, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 19, pp. 21800-21813
Open Access | Times Cited: 39
The Circadian Biology of Heart Failure
Nadim El Jamal, Ronan Lordan, Sarah L. Teegarden, et al.
Circulation Research (2023) Vol. 132, Iss. 2, pp. 223-237
Open Access | Times Cited: 31
Electrical Stimulation Promotes the Vascularization and Functionalization of an Engineered Biomimetic Human Cardiac Tissue
Bingchuan Lu, Min Ye, Jingjing Xia, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Open Access | Times Cited: 31
RUNX1: an emerging therapeutic target for cardiovascular disease
Alexandra Riddell, Martin McBride, Thomas Braun, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 8, pp. 1410-1423
Open Access | Times Cited: 65
Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure
Changhai Tian, Guoku Hu, Lie Gao, et al.
Journal of Molecular and Cellular Cardiology (2020) Vol. 143, pp. 120-131
Open Access | Times Cited: 65
Cardiomyocyte-Derived Exosomes: Biological Functions and Potential Therapeutic Implications
Hui Yu, Zhanli Wang
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 60
Tryptophan: From Diet to Cardiovascular Diseases
Nada Joe Melhem, Soraya Taleb
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9904-9904
Open Access | Times Cited: 49
A new hemostatic agent composed of Zn2+-enriched Ca2+ alginate activates vascular endothelial cells in vitro and promotes tissue repair in vivo
Anne‐Charlotte Ponsen, Richard Proust, Sabrina Soave, et al.
Bioactive Materials (2022) Vol. 18, pp. 368-382
Open Access | Times Cited: 32
Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction
Elisabeth A. Jalink, Amber W. Schonk, Reinier A. Boon, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 8
Heart-on-a-chip systems: disease modeling and drug screening applications
Derrick Butler, Darwin R. Reyes
Lab on a Chip (2024) Vol. 24, Iss. 5, pp. 1494-1528
Closed Access | Times Cited: 7
Human pluripotent stem cell-derived cardiomyocytes for studying energy metabolism
Bärbel Ulmer, Thomas Eschenhagen
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2019) Vol. 1867, Iss. 3, pp. 118471-118471
Open Access | Times Cited: 52
Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
Verena Schwach, Rolf H. Slaats, Robert Passier
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 44
Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterization
Sarah D. Burnett, Alexander D. Blanchette, Weihsueh A. Chiu, et al.
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 8, pp. 887-902
Open Access | Times Cited: 40
An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity
Miguel Godinho de Oliveira Anjos, Marta Fontes Oliveira, Vera Marisa Costa, et al.
Life Sciences (2021) Vol. 280, pp. 119760-119760
Closed Access | Times Cited: 40
The vasculature: a therapeutic target in heart failure?
Guillermo Luxán, Stefanie Dimmeler
Cardiovascular Research (2021) Vol. 118, Iss. 1, pp. 53-64
Open Access | Times Cited: 38
Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure
Yanzhen Li, Daniel J. Song, Lan Mao, et al.
Biomaterials (2020) Vol. 236, pp. 119824-119824
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top